197 related articles for article (PubMed ID: 36631635)
1. Single-cell sequencing of PIT1-positive pituitary adenoma highlights the pro-tumour microenvironment mediated by IFN-γ-induced tumour-associated fibroblasts remodelling.
Lyu L; Jiang Y; Ma W; Li H; Liu X; Li L; Shen A; Yu Y; Jiang S; Li H; Zhou P; Yin S
Br J Cancer; 2023 Apr; 128(6):1117-1133. PubMed ID: 36631635
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
Endocr Relat Cancer; 2019 Dec; 26(12):853-865. PubMed ID: 31645017
[TBL] [Abstract][Full Text] [Related]
3. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
[TBL] [Abstract][Full Text] [Related]
4. Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17.
Zhang A; Xu Y; Xu H; Ren J; Meng T; Ni Y; Zhu Q; Zhang WB; Pan YB; Jin J; Bi Y; Wu ZB; Lin S; Lou M
Theranostics; 2021; 11(8):3839-3852. PubMed ID: 33664865
[No Abstract] [Full Text] [Related]
5. Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.
Dottermusch M; Ryba A; Ricklefs FL; Flitsch J; Schmid S; Glatzel M; Saeger W; Neumann JE; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):16. PubMed ID: 38228887
[TBL] [Abstract][Full Text] [Related]
6. The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Grieve J; Dorward N; Mendoza N; Nair R; Muquit S; Grossman AB; Korbonits M
J Neuroendocrinol; 2021 Dec; 33(12):e13052. PubMed ID: 34708902
[TBL] [Abstract][Full Text] [Related]
7. Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset.
Luo M; Tang R; Wang H
J Neurooncol; 2023 Jul; 163(3):663-674. PubMed ID: 37418134
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Pathological Features of Pit1/SF1 Multilineage Pituitary Neuroendocrine Tumor.
Wang X; Tang H; Bie Z; Wang Y; Yuan R; Zhang Z; Xiong Z; Yang Z; Bi Z; Wang B; Liu P
Neurosurgery; 2024 Jan; ():. PubMed ID: 38289085
[TBL] [Abstract][Full Text] [Related]
9. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
[TBL] [Abstract][Full Text] [Related]
10. Cell diversity and immune infiltration in the parathyroid tumour microenvironment.
Zhang X; Hu Y; Cui M; Wang M; Li X; Zhang Y; Yang S; Hua S; Shen M; Liao Q
Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36602147
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.
Dottermusch M; Schüller U; Hagel C; Saeger W
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12870. PubMed ID: 36527335
[TBL] [Abstract][Full Text] [Related]
12. PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.
Palmieri D; Valentino T; De Martino I; Esposito F; Cappabianca P; Wierinckx A; Vitiello M; Lombardi G; Colao A; Trouillas J; Pierantoni GM; Fusco A; Fedele M
Endocr Relat Cancer; 2012 Apr; 19(2):123-35. PubMed ID: 22199144
[TBL] [Abstract][Full Text] [Related]
13. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
Asa SL; Mete O; Riddle ND; Perry A
Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
[TBL] [Abstract][Full Text] [Related]
14. Overview of the 2022 WHO Classification of Pituitary Tumors.
Asa SL; Mete O; Perry A; Osamura RY
Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.
Nazareth MR; Broderick L; Simpson-Abelson MR; Kelleher RJ; Yokota SJ; Bankert RB
J Immunol; 2007 May; 178(9):5552-62. PubMed ID: 17442937
[TBL] [Abstract][Full Text] [Related]
16. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenomas with multiple cell lineage combinations: clinicopathological features and short-term prognosis.
Tang H; Wang X; Bie Z; Yang Z; Wang B; Li S; Liu P
J Neurosurg; 2023 Sep; 139(3):810-821. PubMed ID: 36708537
[TBL] [Abstract][Full Text] [Related]
18. Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue.
Peculis R; Mandrika I; Petrovska R; Dortane R; Megnis K; Nazarovs J; Balcere I; Stukens J; Konrade I; Pirags V; Klovins J; Rovite V
Front Endocrinol (Lausanne); 2020; 11():313. PubMed ID: 32528411
[TBL] [Abstract][Full Text] [Related]
19. Invasive Pituitary Adenoma-Derived Tumor-Associated Fibroblasts Promote Tumor Progression both In Vitro and In Vivo.
Lv L; Zhang S; Hu Y; Zhou P; Gao L; Wang M; Sun Z; Chen C; Yin S; Wang X; Jiang S
Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):213-221. PubMed ID: 29117616
[TBL] [Abstract][Full Text] [Related]
20. Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.
Zheng L; Yan X; Hu C; Zhang P; Chen Y; Zheng Q; Hu L; Wang M; Li G; Wu P; Jiang C; Tian J; Zhang S; Wang X
Front Endocrinol (Lausanne); 2022; 13():848762. PubMed ID: 35370935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]